A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors.
Cost of living crisis threatens to reverse gains in life expectancy, study finds
The cost of living crisis is set to cut lives short and significantly widen the wealth and health gap between the richest and poorest sectors